Ltr Pharma Fpo has released a press release.
LTP Completes Extractables Study Milestone for SPONTAN
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from LTR Pharma
- Urological Expert Appointed to LTR Scientific Advisory Board
- SPONTAN Expands Patient Access via National Pharmacy Network
- LTR Signs Collaborative Agreement to Develop OMD Nasal Spray
- Investor Presentation
- Commercial Update and Regulatory Progress
Later from LTR Pharma
- SPONTAN 5x Faster Onset Validated in EU Journal
- 18-Month Shelf Life Strengthens SPONTAN Commercialisation
- SPONTAN Case Series - Strong Post-Prostatectomy Results
- Appendix 4E and Annual Report to Shareholders
- FY25 Results Announcement
Follow LTR Pharma into a list and get an email when it puts out news.
Follow LTR Pharma